FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Percy Ivy

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Sachin Gupta; Sally Hunsberger; Percy Ivy; Robert Royds; Larry Rubinstein; Scott A Boerner; Patricia M LoRusso
Meta-analysis of the relationship between dose and benefit in phase I targeted agent trials.
Joanna M Brell; Matthew M Cooney; Joseph A Bokar; Joseph Gibbons; Percy Ivy; Smitha S Krishnamurthi; Neal J Meropol; Linda Rath; Panayiotis Savvides; Afshin Dowlati
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.
Patricia M LoRusso; Sridhar Mani; Daniel Mulkerin; Rachel Neuwirth; Ramesh K Ramanathan; Michelle A Rudek; John Sarantopoulos; Stephen I Shibata; Chris H Takimoto; Karthik Venkatakrishnan; Afshin Dowlati; Dixie Esseltine; Anne Hamilton; Percy Ivy
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Percy Ivy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sachin Gupta; Sally Hunsberger; Percy Ivy; Robert Royds; Larry Rubinstein; Scott A Boerner; Patricia M LoRusso
Meta-analysis of the relationship between dose and benefit in phase I targeted agent trials.
Journal of the National Cancer Institute 2012;104(24):1860-6.
2012: Joanna M Brell; Matthew M Cooney; Joseph A Bokar; Joseph Gibbons; Percy Ivy; Smitha S Krishnamurthi; Neal J Meropol; Linda Rath; Panayiotis Savvides; Afshin Dowlati
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2012;70(4):547-53.
2012: Patricia M LoRusso; Sridhar Mani; Daniel Mulkerin; Rachel Neuwirth; Ramesh K Ramanathan; Michelle A Rudek; John Sarantopoulos; Stephen I Shibata; Chris H Takimoto; Karthik Venkatakrishnan; Afshin Dowlati; Dixie Esseltine; Anne Hamilton; Percy Ivy
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(10):2954-63.
2010: BRIGITTE WIDEMANN; FRANK BALIS; AeRang Kim; Matthew Boron; Nalini Jayaprakash; Aiman Shalabi; Michelle O'Brien; Michelle Eby; Diane E Cole; RF Murphy; Elizabeth Fox; Percy Ivy; Peter Charles Adamson
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(25):3979-86.
2010: Dennis Kuo; Stephanie V Blank; Paul J Christos; Mimi Y Kim; Thomas A Caputo; Bhavana Pothuri; Dawn Hershman; Noah Goldman; Percy Ivy; Carolyn D Runowicz; Franco Muggia; Gary L Goldberg; Mark Einstein
Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study.
Gynecologic oncology 2010;116(3):442-6.
2009: Larry Rubinstein; John Crowley; Percy Ivy; Michael Leblanc; Dan Sargent
Randomized phase II designs.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):1883-90.
2009: Alex A. Adjei; Michaele Christian; Percy Ivy
Novel designs and end points for phase II clinical trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(6):1866-72.
2008: Howard Hochster; Thomas T Chen; Janice M Lu; Day Hills; Joan Sorich; Juliet Escalon; Percy Ivy; Leonard Liebes; Franco Muggia
Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study.
Gynecologic oncology 2008;108(3):500-4.
2008: Anne-Marie Langevin; Mark Bernstein; John Kuhn; Susan M Blaney; Percy Ivy; Junfeng Sun; Zhengjia Chen; Peter Charles Adamson
A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study.
Pediatric blood & cancer 2008;50(3):577-80.
2007: Beth Overmoyer; Pingfu Fu; Charles L Hoppel; Tomas Radivoyevitch; Robert Shenk; Marjie Persons; Paula Silverman; Kelly Robertson; Nicholas P Ziats; Jay K Wasman; Fadi W Abdul-Karim; John A Jesberger; Jeffrey Duerk; Paul Hartman; Shelli Hanks; JONATHAN LEWIN; Afshin Dowlati; Keith R McCrae; Percy Ivy; Scot C Remick
Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5862-8.
2007: Chris H Takimoto; Martin A Graham; Graham Lockwood; Chee M Ng; Andrew Goetz; Dennis Greenslade; Scot C Remick; Sunil Sharma; Sridhar Mani; Ramesh K Ramanathan; Timothy W Synold; James Doroshow; Anne Hamilton; Daniel Mulkerin; Percy Ivy; Merrill J Egorin; Jean L Grem
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(16):4832-9.
2007: Timothy W Synold; Chris H Takimoto; James Doroshow; David R Gandara; Sridhar Mani; Scot C Remick; Daniel Mulkerin; Anne Hamilton; Sunil Sharma; Ramesh K Ramanathan; Heinz-Josef Lenz; Martin Graham; Jeff Longmate; Bennett M Kaufman; Percy Ivy
Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3660-6.
2007: Harold J Burstein; Beth Overmoyer; Rebecca Gelman; Paula Silverman; Jennifer Savoie; Kathryn Clarke; Leda Dumadag; Jerry Younger; Percy Ivy; Eric P Winer
Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.
Investigational new drugs 2007;25(2):161-4.
2005: Afshin Dowlati; Robert A Chapman; Shanmuga Subbiah; Pingfu Fu; Anne Ness; Tania Cortas; Lauren Patrick; Sherrie Reynolds; Natalie Xu; Nathan Levitan; Percy Ivy; Scot C Remick
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.
Investigational new drugs 2005;23(6):563-7.
2005: Afshin Dowlati; Kelly Robertson; Tomas Radivoyevitch; John Waas; Nicholas P Ziats; Paul Hartman; Fadi W Abdul-Karim; Jay K Wasman; John A Jesberger; JONATHAN LEWIN; Keith R McCrae; Percy Ivy; Scot C Remick
Novel Phase I dose de-escalation design trial to determine the biological modulatory dose of the antiangiogenic agent SU5416.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7938-44.
2005: Matthew M Cooney; Kou-Yi Tserng; Vinit Makar; R Jeff McPeak; Stephen T Ingalls; Afshin Dowlati; Beth Overmoyer; Keith R McCrae; Pamela Ksenich; Pierre Lavertu; Percy Ivy; Charles L Hoppel; Scot C Remick
A phase IB clinical and pharmacokinetic study of the angiogenesis inhibitor SU5416 and paclitaxel in recurrent or metastatic carcinoma of the head and neck.
Cancer chemotherapy and pharmacology 2005;55(3):295-300.
2004: BRIGITTE WIDEMANN; FRANK BALIS; Aiman Shalabi; Matthew Boron; Michelle O'Brien; Diane E Cole; Nalini Jayaprakash; Percy Ivy; Valerie P Castle; Karin M Muraszko; Christopher L Moertel; Robert Trueworthy; Robert C Hermann; Ali Moussa; Stuart Hinton; Gregory Reaman; David G Poplack; Peter Charles Adamson
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
Journal of the National Cancer Institute 2004;96(20):1557-9.
2003: SANJAY GOEL; A Bulgaru; Howard Hochster; Scott Wadler; William C Zamboni; Merrill J Egorin; Percy Ivy; L Leibes; Franco Muggia; Graham Lockwood; E Harvey; G Renshaw; Sridhar Mani
Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(11):1682-7.
2003: Chris H Takimoto; Scot C Remick; Sunil Sharma; Sridhar Mani; Ramesh K Ramanathan; James Doroshow; Anne Hamilton; Daniel Mulkerin; Martin Graham; Graham F Lockwood; Percy Ivy; Merrill J Egorin; Dennis Greenslade; Andrew Goetz; Jean L Grem
Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working group.
Seminars in oncology 2003;30(4 Suppl 15):20-5.
2003: James Doroshow; Timothy W Synold; David R Gandara; Sridhar Mani; Scot C Remick; Daniel Mulkerin; Anne Hamilton; Sunil Sharma; Ramesh K Ramanathan; Heinz-Josef Lenz; Martin Graham; Jeff Longmate; Chris H Takimoto; Percy Ivy
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group.
Seminars in oncology 2003;30(4 Suppl 15):14-9.
2003: Chris H Takimoto; Scot C Remick; Sunil Sharma; Sridhar Mani; Ramesh K Ramanathan; James Doroshow; Anne Hamilton; Daniel Mulkerin; Martin Graham; Graham F Lockwood; Percy Ivy; Merrill J Egorin; Barbara Schuler; Dennis Greenslade; Andrew Goetz; Ronald Knight; Rebecca Thomas; Brian P Monahan; William Dahut; Jean L Grem
Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2664-72.
2003: SANJAY GOEL; Scott Wadler; Anthony Hoffman; Fabio Volterra; Cheryl Baker; Elliot Nazario; Percy Ivy; Alyson Silverman; Sridhar Mani
A phase II study of rebeccamycin analog NSC 655649 in patients with metastatic colorectal cancer.
Investigational new drugs 2003;21(1):103-7.
2002: Sridhar Mani; Martin A Graham; David B Bregman; Percy Ivy; Stephen G Chaney
Oxaliplatin: a review of evolving concepts.
Cancer investigation 2002;20(2):246-63.
2001: Afshin Dowlati; C L Hoppel; Stephen T Ingalls; Susan Majka; X Li; N Sedransk; T Spiro; Stanton L Gerson; Percy Ivy; Scot C Remick
Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2309-18.